Phoenix Biotechnology Lands $2,708,264 New Funding
Feed Type
Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=56c356ad-3c34-4c69-bf24-a03191a1474f&Preview=1
Date 10/7/2010
Company Name Phoenix Biotechnology
Mailing Address 8626 Tesoro Dr. San Antonio, TX 78217
Company Description The company was created through the acquisition of the assets of Anvirlat, Inc., a privately held Nevada corporation controlled by Messrs. Addington and Kost, current officers and directors of the company. Company research has led to the development of an anti-neoplastic agent that the company has entered into USFDA Phase I Clinical Trials in 2007.